Cargando…

Cilostazol for secondary stroke prevention: systematic review and meta-analysis

BACKGROUND: Stroke is one of the leading causes of death worldwide. Cilostazol, an antiplatelet and phosphodiesterase 3 inhibitor, has not been clearly established for ischaemic stroke use. We aim to determine the efficacy and safety of cilostazol for secondary stroke prevention. METHODS: MEDLINE, E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Choon Han, Wu, Andrew GR, Sia, Ching-Hui, Leow, Aloysius ST, Chan, Bernard PL, Sharma, Vijay Kumar, Yeo, Leonard LL, Tan, Benjamin YQ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485237/ https://www.ncbi.nlm.nih.gov/pubmed/33542092 http://dx.doi.org/10.1136/svn-2020-000737

Ejemplares similares

Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Are Associated with Recurrent Ischemic Stroke in Patients with Embolic Stroke of Undetermined Source
por: Li, Tony Y.W., et al.
Publicado: (2022)

Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review
por: Tu, Tian Ming, et al.
Publicado: (2020)

Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Toh, Emma M. S., et al.
Publicado: (2022)

Traumatic Pneumothorax Secondary to Acupuncture Needling
por: Sia, Ching-Hui, et al.
Publicado: (2018)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
por: Galyfos, George, et al.
Publicado: (2017)

Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2013)

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature
por: Tan, Ying-Kiat, et al.
Publicado: (2020)

Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
por: McHutchison, Caroline, et al.
Publicado: (2020)

Ambient Air Pollution and Acute Ischemic Stroke—Effect Modification by Atrial Fibrillation
por: Tan, Benjamin Yong-Qiang, et al.
Publicado: (2022)

Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale
por: Toh, Keith Zhi Xian, et al.
Publicado: (2023)

Retraction Note: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis
por: Qian, Yining, et al.
Publicado: (2015)

Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
por: Zhou, Lily W., et al.
Publicado: (2022)

Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review
por: Tharmaraja, Thahesh, et al.
Publicado: (2022)

Left Ventricular Ejection Fraction Association with Acute Ischemic Stroke Outcomes in Patients Undergoing Thrombolysis
por: Chee, Ryan C. H., et al.
Publicado: (2023)

The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis
por: Chai, Erqing, et al.
Publicado: (2022)

How an Occluded Artery Recanalizes during Acute Stroke Thrombolysis
por: Sharma, Vijay K, et al.
Publicado: (2015)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS
por: Bhatt, Nejal M., et al.
Publicado: (2015)

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis
por: Shi, LiGen, et al.
Publicado: (2014)

Association of Shunt Size and Long-Term Clinical Outcomes in Patients with Cryptogenic Ischemic Stroke and Patent Foramen Ovale on Medical Management
por: Lim, Isis Claire Z. Y., et al.
Publicado: (2023)

Diffusion-negative MRI in acute ischemic stroke: a case report
por: Rathakrishnan, Rahul, et al.
Publicado: (2008)

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
por: Hoshino, Haruhiko, et al.
Publicado: (2023)

Bridging Thrombolysis versus Direct Mechanical Thrombectomy in Stroke Due to Basilar Artery Occlusion
por: Siow, Isabel, et al.
Publicado: (2022)

Rationale and design of a randomized trial of early intensive blood pressure lowering on cerebral perfusion parameters in thrombolysed acute ischemic stroke patients
por: Sharma, Vijay K., et al.
Publicado: (2018)

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke
por: Lee, Su-Yun, et al.
Publicado: (2008)

Risk of Liver Fibrosis Is Associated with More Severe Strokes, Increased Complications with Thrombolysis, and Mortality
por: Toh, Emma M. S., et al.
Publicado: (2023)

Long-Term Trends in Ischemic Stroke Incidence and Risk Factors: Perspectives from an Asian Stroke Registry
por: Tan, Benjamin Y.Q., et al.
Publicado: (2020)

Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review
por: Thong, Elizabeth Hui En, et al.
Publicado: (2023)

Cilostazol for the prevention of pneumonia: a systematic review
por: Nakashima, Hirotaka, et al.
Publicado: (2018)

The Role of Carbon Dioxide in the Rat Acute Stroke Penumbra
por: Yeo, Leonard L., et al.
Publicado: (2022)

Non-occlusive mesenteric ischemia and the role of cilostazol in its management
por: Murthy, K. A. Sudharshana, et al.
Publicado: (2012)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients
por: Heo, Sung Hyuk, et al.
Publicado: (2012)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation
por: Kawanabe, Yoshifumi, et al.
Publicado: (2012)

Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
por: Park, Joon Beom, et al.
Publicado: (2023)

Prevalence and incidence of stroke, white matter hyperintensities, and silent brain infarcts in patients with chronic heart failure: A systematic review, meta-analysis, and meta-regression
por: Tan, Sean, et al.
Publicado: (2022)

Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
por: Lima, Paulo Roberto da Silva, et al.
Publicado: (2016)

Review of Toyoda K, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischemic stroke in Japan. Lancet Neurol. 2019 Jun;18(6):539-548
por: Lo, Benjamin W. Y., et al.
Publicado: (2020)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus-2 infection: a systematic review
por: Cho, Jiacai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iorp4av37ak88c56m6q8lhg7g0